Document Type : Original Article
Authors
1 Department of Clinical Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran
2 Department of Clinical Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 Department of Pharmaceutical Care, Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4 Department of Clinical Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran Department of Pharmaceutical Care, Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abstract
Objective: Clinical pharmacy services are improving in hospitals. For assessing the impact
of these services, first it is important to exactly describe them by categorizing into types,
severity, resolution, and accuracy. The objective of this study is to provide a detailed analysis
of the clinical pharmacists’ services performed on in‑patients in a teaching hospital during
28 months. Setting: Masih Daneshvari hospital, Tehran, Iran.
Methods: This is a descriptive study. The authors retrospectively reviewed the notes of
all services and entered them in a designed SPSS sheet. Documentation was carried out
based on the “findings, assessment, resolution, and monitoring” method. The data were
descriptively analyzed. Main outcome measure: Types, subtypes, severities, resolutions, and
accuracies of services were defined, documented, and analyzed.
Findings: In total 3152 records(2227 interventions and 925 visits with no intervention) were
classified and analyzed in this study. Among all types of interventions, “improper medication
use” (36.2%) was the most frequent intervention and among categories (subgroups) of
“improper medication use,” “untreated indication” was the most frequent (23.7%). From the
aspect of severity, 75.4% of interventions were estimated as of minor potential inconvenience
to the patient (severity degree 1). Most interventions (78%) were finally recommended to
the prescriber and 97.6% of interventions were considered accurate on further evaluation.
Conclusion: Clinical pharmacists’ interventions are highly demanded in the hospitals. Based
on the results of this study, conditions needing medication to prevent later complications
in the course of therapy are sometimes ignored, which emphasizes the positive role of the
clinical pharmacists’ involvements in clinical teams to improve outcome.
Keywords
SHPA standards of practice for clinical pharmacy. J Pharm
Pract Res 2005;35:122‑46.
2. Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical
pharmacists and inpatient medical care: Asystematic review.
Arch Intern Med 2006;166:955‑64.
3. MacKinnon G. Analysis of pharmacy student interventions
collected via an internet based system. Am J Pharm Educ
2003;67:1‑12.
4. Scarsi KK, Fotis MA, Noskin GA. Pharmacist participation in
medical rounds reduces medication errors. Am J Health Syst
Pharm 2002;59:2089‑92.
5. Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA.
Pharmacists on rounding teams reduce preventable adverse
drug events in hospital general medicine units. Arch Intern
Med 2003;163:2014‑8.
6. Salamzadeh J. Clinical pharmacy in Iran: Where do we stand?
Iran J Pharm Res 2004;3:1‑2.
7. Fahimi F. Implementation of a clinical pharmacy
education program in a teaching hospital: Resident
oriented documentation and intervention. Iran J Pharm Res
2010;9:297‑302.
8. Baniasadi S, Fahimi F, Shalviri G. Developing an adverse drug
reaction reporting system at a teaching hospital. Basic Clin
Pharmacol Toxicol 2008;102:408‑11.
9. Fahimi F, Baniasadi S, Amini S. Adverse drug reactions in the
post coronary care unit inpatients of a teaching hospital. Iran
J Pharm Res 2008;7:223‑8.
10. Baniasadi S, Fahimi F. Adverse drug reactions in a pulmonary
teaching hospital: Incidence, pattern, seriousness, and
preventability. Curr Drug Saf 2011;6:230‑6.
11. Fahimi F, Baniasadi S, Malekmohammad M. Neurologic
and Psychotic Reaction Induced by Lidocaine. Journal of
Bronchology 2007;14:57-8.
12. Baniasadi S, Fahimi F, Mansouri D. Serum SicknessLike Reaction Associated with Two Cephalosporins,
Cefuroxime and Ceftriaxone. The Annals of Pharmacotherapy
2007;41:1318-9.
13. Fahimi F, Moradi M, Safarnavadeh T, NamdarR. Review of the
management of community acquired pneumonia in a teaching
hospital: Assessment of the role of established guidelines.
Tanaffos 2007;6:35.
14. Tavallaee M, Fahimi F, Kiani S. Drug‑use patterns in an
intensive care unit of a hospital in Iran: An observational
prospective study. Int J Pharm Pract 2010;18:370‑6.
15. Talasaz AH, Jahangard‑Rafsanjani Z, Ziaie S, Fahimi F.
Evaluation of the pattern of human albumin utilization at a
university affiliated hospital. Arch Iran Med 2012;15:85‑7.
16. Fahimi F, Baniasadi S, Behzadnia N, Varahram F, Ghazi
Tabatabaie L. Enoxaparin utilization evaluation: an
observational prospective study in medical inpatients. Iranian
J Pharm Res 2008;7:77-82.
17. Fahimi F, Emami S, Rashid Farokhi F. The rate of antibiotic
dosage adjustment in renal dysfunction at a university hospital.
Iranian Journal of Pharmaceutical Research 2013, [In press].
18. Emami S, Riazi Esfahani H, Rashid Farokhi F, Fahimi F.
Assessment of drug dose adjustment in patients with
kidney disease at a tertiary care hospital: Opportunities for
pharmacist involvement. International Journal of Pharmacy
and Pharmaceutical Sciences 2013 [In press].
19. Baniasadi S, Fahimi F, Namdar R. Development of an adverse
drug reaction bulletin in a teaching hospital. Formulary
2009;44:333‑5.
20. Fahimi F, Sharif Kashani B, Hossein Ahmadi Z, Salamzadeh J,
Namdar R, Mousavi S, et al. The first pharmacist‑based
warfarin‑monitoring service in Iran. J Pharm Health Serv Res
2011;2:59‑62.
21. Fahimi F, Sistanizad M, Abrishami R, Baniasadi S. An
observational study of errors related to the preparation and
administration of medications given by infusion devices in a
teaching hospital. Iran J Pharm Res 2007;6:295‑9.
22. Fahimi F, Abbasi Nazari M, Abrishami R, Sistanizad M,
Mazidi T, Faghihi T, et al. Transcription errors observed in a
teaching hospital. Arch Iran Med 2009;12:173‑5.
23. Fahimi F, Ariapanah P, Faizi M, Shafaghi B, Namdar R, Tavakoli
Ardakani M. Errors in preparation and administration of
intravenous medications in the intensive care unit of a teaching
hospital: an education program: Resident observational study.
Aust Crit Care. 2008;21:110-6.
24. Fahimi F, Baniasadi S, Najafizadeh K. Does switch to another
dosage form of Neoral increase the risk of medication error?
Ann Transplant 2009;14:58-60.
25. Haslett TM, Kay BG, Weissfellner H. Documenting concurrent
clinical pharmacy interventions. Hosp Pharm 1990;25:351‑5, 359.
26. Canaday BR, Yarborough PC. Documenting pharmaceutical
care: Creating a standard. Ann Pharmacother 1994;28:1292‑6.
27. Schwinghammer TL. Instructor’s Guide to Accompany
Pharmacotherapy Casebook: A Patient Focused Approach,
6th ed. New York City, U.S: McGraw‑Hill Companies; 2005. p. 70.
28. SchwinghammerTL, KoehlerJM. Pharmacotherapy Casebook:
A Patient‑Focused Approach, 7th ed. New York City, U.S:
McGraw‑Hill Companies; 2009. p. 29.
29. Allan EL, Barker KN. Fundamentals of medication error
research. Am J Hosp Pharm 1990;47:555‑71.
30. Knudsen P, Herborg H, Mortensen AR, Knudsen M,
Hellebek A. Preventing medication errors in community
pharmacy: Frequency and seriousness of medication errors.
Qual Saf Health Care 2007;16:291‑6.
31. Haavik S, Soeviknes S, Erdal H, Kjonniksen I, GuttormsenAB,
Granas AG. Prescriptions from general practitioners and in
hospital physicians requiring pharmacists’ interventions.
Pharmacoepidemiol Drug Saf 2011;20:50‑6.
32. Dooley MJ, Allen KM, Doecke CJ, Galbraith KJ, Taylor GR,
Bright J, et al. A prospective multicentre study of pharmacist
initiated changes to drug therapy and patient management in
acute care government funded hospitals. Br J Clin Pharmacol
2004;57:513‑21.
33. Jones JD, Jackson SH, Gomez A, Hollinger C, Rivers G.
Evaluation of pharmacy students’ clinical interventions on a
general medicine practice experience. Pharm Pract 2011;9:11‑5.
34. Struck P, Pedersen KH, Moodley P, Rasmussen M. A pilot
study of pharmacist‑initiated interventions in drug therapy
in an Australian paediatric hospital. Eur J Hosp Pharm Sci
2007;13:105‑12.
35. Hawksworth GM, CorlettAJ, Wright DJ, Chrystyn H. Clinical
pharmacy interventions by community pharmacists during
the dispensing process. Br J Clin Pharmacol 1999;47:695‑700.
36. Davydov L, Caliendo GC, Smith LG, Mehl B. Analysis of
clinical intervention documentation by dispensing pharmacists in a teaching hospital. Hosp Pharm 2003;38:346‑50.
37. Olson LM, Desai S, Soto ML, Namazifard Sh, Quelland AK,
Erstad BL. Evaluation of pharmacists’ interventions at a
university teaching hospital. Can J Hosp Pharm 2005;58:20‑5.
38. Knez L, Laaksonen R, Duggan C. Evaluation of clinical
interventions made by pharmacists in chemotherapy
preparation. Radiol Oncol 2010;44:249‑56.
39. MorrisonA, WertheimerAI. Evaluation of studies investigating
the effectiveness of pharmacists’ clinical services. Am J Health
Syst Pharm 2001;58:569‑77.
40. Khalili H, Dashti‑Khavidaki S, Talasaz AH, Mahmoudi L,
Eslami K, Tabeefar H. Is deep vein thrombosis prophylaxis
appropriate in the medical wards? A clinical pharmacists’
intervention study. Pharm World Sci 2010;32:594‑600.
41. Dashti‑Khavidaki S, Khalili H, Hamishekar H, Shahverdi S.
Clinical pharmacy services in an Iranian teaching hospital:
A descriptive study. Pharm World Sci 2009;31:696‑700.
)